A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.


Updates from The Motley Fool

Latest updates on XOMA from Fool.com.  The Fool has written over 100 articles on XOMA.
Why XOMA Shares Are Crashing

What: After reporting third quarter financial results and updating investors on its clinical sta...

Is Xoma Corporation A Buy?

Source: Flickr user Ali T. Clinical stage biotech stocks can have nausea-inspiring pops-and-drops...

Why XOMA Corp. Shares Tanked

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Why XOMA Corp. Shares Popped

Although we don't believe in timing the market or panicking over market movements, we do like to ...

Down 30%, Worth a Look

It's never a good sign when the first paragraph of a press release announcing clinical trial r...

5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's b...



Stock Performance

View Interactive XOMA Charts
Sponsored by

Key Data Points

Primary metrics and data points about XOMA.
Current Price: $5.59
Prev Close: $5.55
Open: $5.49
Bid: $5.53
Ask: $5.67
Day's Range: $5.45 - $5.70
52wk Range: $4.70 - $28.80
Volume: 6,610
Avg Vol 80,140
Market Cap: $664M
P/E (ttm): -3.54
EPS (ttm): ($1.57)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about XOMA.
CAPS Rating 2 out of 5
 
330 Outperform
39 Underperform
CAPS All Stars
 
31 Outperform
15 Underperform

How do you think XOMA will perform against the market?



You pick for XOMA is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John Varian, CEO

85% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for XOMA.

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers